Martin Widschwendter
Cited by
Cited by
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
DJ Weisenberger, KD Siegmund, M Campan, J Young, TI Long, ...
Nature genetics 38 (7), 787-793, 2006
Epigenetic stem cell signature in cancer
M Widschwendter, H Fiegl, D Egle, E Mueller-Holzner, G Spizzo, C Marth, ...
Nature genetics 39 (2), 157-158, 2007
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ...
The Lancet 387 (10022), 945-956, 2016
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ...
Genome research 20 (4), 440-446, 2010
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
D Schramek, A Leibbrandt, V Sigl, L Kenner, JA Pospisilik, HJ Lee, ...
Nature 468 (7320), 98-102, 2010
DNA methylation and breast carcinogenesis
M Widschwendter, PA Jones
Oncogene 21 (35), 5462-5482, 2002
FBXW7/hCDC4 is a general tumor suppressor in human cancer
S Akhoondi, D Sun, N von der Lehr, S Apostolidou, K Klotz, A Maljukova, ...
Cancer research 67 (19), 9006-9012, 2007
DNA methylation in serum of breast cancer patients: an independent prognostic marker
HM Muller, A Widschwendter, H Fiegl, L Ivarsson, G Goebel, E Perkmann, ...
Cancer research 63 (22), 7641-7645, 2003
Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen
M Widschwendter, KD Siegmund, HM Müller, H Fiegl, C Marth, ...
Cancer research 64 (11), 3807-3813, 2004
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
EL Goode, G Chenevix-Trench, H Song, SJ Ramus, M Notaridou, ...
Nature genetics 42 (10), 874-879, 2010
Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer
M Widschwendter, J Berger, M Hermann, HM Müller, A Amberger, ...
Journal of the National Cancer Institute 92 (10), 826-832, 2000
Methylation changes in faecal DNA: a marker for colorectal cancer screening?
HM Müller, M Oberwalder, H Fiegl, M Morandell, G Goebel, M Zitt, ...
The Lancet 363 (9417), 1283-1285, 2004
An epigenetic signature in peripheral blood predicts active ovarian cancer
AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, SA Gayther, ...
PloS one 4 (12), e8274, 2009
hCDC4 Gene Mutations in Endometrial Cancer
CH Spruck, H Strohmaier, O Sangfelt, HM Muller, M Hubalek, ...
Cancer research 62 (16), 4535-4539, 2002
Tubal ligation and the risk of ovarian cancer: review and meta-analysis
D Cibula, M Widschwendter, O Májek, L Dusek
Human reproduction update 17 (1), 55-67, 2011
Menopause accelerates biological aging
ME Levine, AT Lu, BH Chen, DG Hernandez, AB Singleton, L Ferrucci, ...
Proceedings of the National Academy of Sciences 113 (33), 9327-9332, 2016
DNA hypomethylation and ovarian cancer biology
M Widschwendter, G Jiang, C Woods, HM Müller, H Fiegl, G Goebel, ...
Cancer research 64 (13), 4472-4480, 2004
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients
H Fiegl, S Millinger, E Mueller-Holzner, C Marth, C Ensinger, A Berger, ...
Cancer research 65 (4), 1141-1145, 2005
Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies
AE Teschendorff, J Zhuang, M Widschwendter
Bioinformatics 27 (11), 1496-1505, 2011
Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer
M Widschwendter, J Berger, G Daxenbichler, E Müller-Holzner, ...
Cancer research 57 (19), 4158-4161, 1997
The system can't perform the operation now. Try again later.
Articles 1–20